Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nandrolone decanoate therapy and physiotherapy/diet in sarcopenia
2024-517178-48-00Phase 2Authorised
- Sponsor
- National Institute of Geriatrics, Rheumatology and Rehabilitation
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sarcopenia comparing Nandrolone decanoate arm with Placebo arm (2 arms). Primary endpoints: Change in SPPB score and Change in 400-meter walk test time. Planned start Oct 2024; status: authorised.
02
Drugs
nandrolone
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on 2024-517178-48-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517178-48-00.